Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.
Cazes A, Lopez-Delisle L, Tsarovina K, Pierre-Eugène C, De Preter K, Peuchmaur M, Nicolas A, Provost C, Louis-Brennetot C, Daveau R, Kumps C, Cascone I, Schleiermacher G, Prignon A, Speleman F, Rohrer H, Delattre O, Janoueix-Lerosey I.
Cazes A, et al. Among authors: prignon a.
Oncotarget. 2014 May 15;5(9):2688-702. doi: 10.18632/oncotarget.1883.
Oncotarget. 2014.
PMID: 24811913
Free PMC article.